[(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate

C11H15BrO7 — CID 10903894

IUPAC[(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate
SMILESCC(=O)OC[C@H]1OC(Br)[C@H](OC(C)=O)[C@@H]1OC(C)=O
InChIInChI=1S/C11H15BrO7/c1-5(13)16-4-8-9(17-6(2)14)10(11(12)19-8)18-7(3)15/h8-11H,4H2,1-3H3/t8-,9-,10-,11?/m1/s1
InChIKeyWIDXXHUKKJXPEP-QHPFDFDXSA-N
MW339.14 g/mol
LogP0.53
Rot. Bonds4

About [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate

[(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate (PubChem CID 10903894) has the molecular formula C11H15BrO7 and a molecular weight of 339.14 g/mol. Its IUPAC name is [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate.

Molecular Properties

Compound Name[(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate
PubChem CID10903894
Molecular FormulaC11H15BrO7
Molecular Weight339.14 g/mol
Exact Mass338.00
IUPAC Name[(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate
SMILESCC(=O)OC[C@H]1OC(Br)[C@H](OC(C)=O)[C@@H]1OC(C)=O
InChIInChI=1S/C11H15BrO7/c1-5(13)16-4-8-9(17-6(2)14)10(11(12)19-8)18-7(3)15/h8-11H,4H2,1-3H3/t8-,9-,10-,11?/m1/s1
InChIKeyWIDXXHUKKJXPEP-QHPFDFDXSA-N
XLogP0.53
TPSA88.13 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500339.14
LogP ≤ 50.53
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(3R,4S,5R,6R)-3,4,5-triacetyloxy-6-bromooxan-2-yl]methyl acetate
CID 46780904
[(3R,5S,6S)-3,4,5-triacetyloxy-6-bromooxan-2-yl]methyl acetate
CID 90250816
[(2R,3R,4S,5R)-3,4,5-triacetyloxy-6-bromooxan-2-yl]methyl acetate
CID 11729291
[(2R,3R,4S,5S,6R)-3,4-diacetyloxy-5,6-dibromooxan-2-yl]methyl acetate
CID 11026413
[(2R,5R)-3,4-diacetyloxy-5-(acetyloxymethyl)oxolan-2-yl]methyl acetate
CID 131700350
[(5R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]methyl acetate
CID 118601719
[(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-bromooxan-2-yl]methyl 2-chloroacetate
CID 87432565
(3-acetyloxy-6-bromo-4-fluoro-5-methyloxan-2-yl)methyl acetate
CID 58981665
[(2R,3S,4S,5S,6R)-4-acetamido-3,5-diacetyloxy-6-bromooxan-2-yl]methyl acetate
CID 54215769
[(2R,3R,4R,5S)-3,4,5-triacetyloxy(513C)oxolan-2-yl]methyl acetate
CID 11461323
[(2R,3S,5S)-3,4,5-triacetyloxyoxolan-2-yl]methyl acetate
CID 24802529
[(2S,3R,4S,5R)-3,4-diacetyloxy-5-sulfanyloxolan-2-yl]methyl acetate
CID 91464161

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate?
The IUPAC name of [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate (CID 10903894) is [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate.
What is the SMILES notation for [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate?
The canonical SMILES for [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate is CC(=O)OC[C@H]1OC(Br)[C@H](OC(C)=O)[C@@H]1OC(C)=O.
What is the InChIKey of [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate?
The InChIKey is WIDXXHUKKJXPEP-QHPFDFDXSA-N. The full InChI is InChI=1S/C11H15BrO7/c1-5(13)16-4-8-9(17-6(2)14)10(11(12)19-8)18-7(3)15/h8-11H,4H2,1-3H3/t8-,9-,10-,11?/m1/s1.
What are the key properties of [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate?
[(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate has a molecular weight of 339.14 g/mol, XLogP of 0.53, 4 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R)-3,4-diacetyloxy-5-bromooxolan-2-yl]methyl acetate is sourced from PubChem (CID 10903894), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).